Spots Global Cancer Trial Database for concurrent chemotherapy
Every month we try and update this database with for concurrent chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study. | NCT06020885 | Esophageal Squa... | Split-course hy... Induction chemo... Concurrent chem... | 18 Years - 80 Years | Sun Yat-sen University | |
IORT Versus CCRT for Pancreatic Cancer | NCT02981641 | Pancreatic Canc... | Intraoperative ... Sequential chem... Three dimension... Concurrent chem... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy | NCT05622474 | Nasopharyngeal ... | Induction chemo... Concurrent chem... IMRT | 18 Years - 70 Years | Sun Yat-sen University | |
Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer | NCT01928589 | Breast Cancer Adenocarcinoma ... | PBI with sequen... PBI with concur... | 18 Years - 100 Years | Indiana University | |
Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC | NCT04951063 | Locally Advance... | Hypofractionate... Concurrent chem... Consolidation i... | 18 Years - 75 Years | Sun Yat-sen University | |
Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors | NCT02921984 | Salivary Gland ... Head and Neck C... | Docetaxel Intensity-modul... Pemetrexed Cisplatin | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study | NCT04583254 | Cervical Cancer | External beam r... External beam r... Concurrent Chem... | 18 Years - | Lawson Health Research Institute | |
Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma | NCT02610556 | Nasopharyngeal ... | Cisplatin 2 Docetaxel Cisplatin 1 Intensity-modul... | 18 Years - 65 Years | Sun Yat-sen University | |
Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial | NCT05331131 | Cancer of Head ... Mucositis Oral Pharyngeal Muco... | Ketamine Topica... | 18 Years - 70 Years | Northwell Health | |
Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women | NCT01594099 | Cervical Cancer | irradiation Cisplatin liposome paclit... | 65 Years - 80 Years | Health Science Center of Xi'an Jiaotong University | |
Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma | NCT02786641 | Nasopharyngeal ... | Docetaxel Cisplatin 1 Xeloda IMRT Cisplatin 2 | 18 Years - 65 Years | Sun Yat-sen University | |
Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC | NCT04951063 | Locally Advance... | Hypofractionate... Concurrent chem... Consolidation i... | 18 Years - 75 Years | Sun Yat-sen University | |
Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene | NCT03905317 | Lung Adenocarci... | Bevacizumab Inj... chest radiation concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer | NCT02573506 | Non-small Cell ... | split-course ra... Concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma | NCT03904563 | Lung Adenocarci... | Bevacizumab chest radiation concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
IORT Versus CCRT for Pancreatic Cancer | NCT02981641 | Pancreatic Canc... | Intraoperative ... Sequential chem... Three dimension... Concurrent chem... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
Hypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLC | NCT03900117 | Non-small Cell ... | split-course ra... concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | NCT02012062 | Nasopharyngeal ... | TPF neoadjuvant... Concurrent chem... Concurrent nimo... Radical radioth... | 18 Years - 70 Years | Fudan University | |
Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | NCT02012062 | Nasopharyngeal ... | TPF neoadjuvant... Concurrent chem... Concurrent nimo... Radical radioth... | 18 Years - 70 Years | Fudan University | |
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer | NCT00140556 | Head and Neck C... Pharynx Cancer | Chemoradiothera... Cisplatin Bevacizumab Erlotinib | 18 Years - | Duke University | |
Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer | NCT03006575 | Non-small Cell ... | split-course ra... concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer | NCT01928589 | Breast Cancer Adenocarcinoma ... | PBI with sequen... PBI with concur... | 18 Years - 100 Years | Indiana University | |
Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma | NCT05979961 | Nasopharyngeal ... | IMRT and concur... gemcitabine and... | 18 Years - 70 Years | Sun Yat-sen University | |
Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors | NCT02921984 | Salivary Gland ... Head and Neck C... | Docetaxel Intensity-modul... Pemetrexed Cisplatin | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer | NCT02923258 | Oral Cavity Squ... | Docetaxel Cisplatin IMRT | 18 Years - 75 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer | NCT02573506 | Non-small Cell ... | split-course ra... Concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer | NCT03661567 | Non-small Cell ... | chest radiation concurrent chem... Methylprednisol... | 18 Years - 75 Years | Sun Yat-sen University | |
Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer | NCT02923258 | Oral Cavity Squ... | Docetaxel Cisplatin IMRT | 18 Years - 75 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer | NCT03659578 | Non-small Cell ... | Concurrent chem... split-course ra... thymosin alpha ... | 18 Years - 75 Years | Sun Yat-sen University | |
Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer | NCT03006575 | Non-small Cell ... | split-course ra... concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer | NCT00101582 | Mucositis Solid Tumors Stomatitis Head and Neck C... Squamous Cell C... | Placebo palifermin cisplatin chemo... Radiotherapy | 18 Years - | Swedish Orphan Biovitrum | |
Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer | NCT03661567 | Non-small Cell ... | chest radiation concurrent chem... Methylprednisol... | 18 Years - 75 Years | Sun Yat-sen University | |
Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC | NCT04951063 | Locally Advance... | Hypofractionate... Concurrent chem... Consolidation i... | 18 Years - 75 Years | Sun Yat-sen University | |
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer | NCT03955367 | Uterine Cervica... | Prophylactic ex... Pelvic irradiat... Intracavitary b... Concurrent chem... | 18 Years - 70 Years | Peking Union Medical College Hospital | |
A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | NCT00705627 | Nasopharyngeal ... | neoadjuvant che... | 18 Years - 60 Years | Sun Yat-sen University | |
Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer | NCT04212052 | Non-small Cell ... | split-course ra... concurrent chem... consolidation i... | 18 Years - 75 Years | Sun Yat-sen University | |
Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | NCT03290820 | Nasopharyngeal ... | Radiotherapy Concurrent chem... Aspirin | 18 Years - 70 Years | Sun Yat-sen University | |
Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma | NCT00778908 | Nasopharyngeal ... | Late-course acc... Concomitant cis... Conventionally ... | 18 Years - 70 Years | Guangxi Medical University | |
Study of Split-course Chemoradiotherapy For Postoperative Locoregional Recurrence Of Non-small Cell Lung Cancer | NCT03006575 | Non-small Cell ... | split-course ra... concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses | NCT05114707 | Nasal Cavity Ca... Paranasal Sinus... Camrelizumab Induction Chemo... Intensity Modul... Concurrent Chem... | camrelizumab | 18 Years - 65 Years | Sun Yat-sen University | |
Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer | NCT04275687 | Loco-regionally... | thoracic irradi... Concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma | NCT05062005 | Locally Advance... | Induction Chemo... Concurrent Chem... Definitive Radi... | 18 Years - 65 Years | First Affiliated Hospital, Sun Yat-Sen University | |
Bevacizumab After Chemoradiotherapy For Locally Advanced Lung Adenocarcinoma | NCT03904563 | Lung Adenocarci... | Bevacizumab chest radiation concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University |